History

Daryl Yurek spearheaded a $6 million second chance financing initiative for SpectraScience in Minneapolis, Minnesota. The company had initially been working on a photoablation laser for treating coronary arterial diseases, but the project faced setbacks. However, with Daryl’s guidance, the lasers were redirected toward a new purpose. Today, SpectraScience offers a simple yet highly effective method for early diagnosis of colorectal cancer, which greatly improves recovery rates. “Our WavSTAT Optical Biopsy System® utilizes light to accurately diagnose tissue health. Through our patented technology, we can instantly determine if tissue is normal, pre-cancerous, or cancerous, without the need for an expensive physical biopsy”